Clinical Trials in Los Angeles

Showing 4021-4040 of 16,901 trials

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

NCT03266640

CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovirus (CMV) infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD

Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder

New York Medical College20 participantsStarted Nov 2018

Los Angeles, California, United States • San Francisco, California, United States • Indianapolis, Indiana, United States +6 more locations

RECRUITINGPhase 2< 1 mile

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

NCT03266627

Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in in children, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant. Funding Source: FDA OOPD

AdenovirusPrimary Immune Deficiency Disorder

New York Medical College20 participantsStarted Nov 2018

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +7 more locations

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Find Trials by Condition in Los Angeles

The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

Hemodynamic-GUIDEd Management of Heart Failure

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

Intranasal Oxytocin for the Treatment of Alcohol Use Disorder

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia